Avenue Therapeutics, Inc.Avenue Therapeutics, Inc.Avenue Therapeutics, Inc.

Avenue Therapeutics, Inc.

No trades
See on Supercharts

ATXI fundamentals

Avenue Therapeutics, Inc. earnings per share and revenue

ATXI earnings per share for the last quarter are -6.43 USD whereas the estimation was -1.05 USD which accounts for -512.38% surprise. Also watch annual changes over time to get a bigger picture of ATXI earnings per share and revenue dynamics.

Next report date
Report period
EPS estimate
Revenue estimate
EPS
‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Revenue
‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise